Tech Company Financing Transactions

CXL Ophthalmics Funding Round

CXL Ophthalmics closed a $32 million Series A venture capital round on 10/1/2022. Investors included AXA Investment Managers and private investors.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A

AXA Investment Managers (Lead Investor)

Proceeds Purpose
The company intends to use the funds to support the advancement of its cross-linking system, EpiSmart, through Phase 3 trials on the way to a New Drug Application with FDA.

Company Information

Company Status
Private & Independent
Healthcare Services
Mailing Address
4354 Manchester Ave.
Encinitas, CA 92024
Email Address
CXLO is developing a minimally?invasive treatment for ectatic corneal disease that can bring early intervention to millions of patients globally.?Our EpiSmart approach is a transformative cross-linking system designed to treat keratoconus without?disrupting?the epithelium, allowing for a?rapid return to normal activities.
CXL Ophthalmics LinkedIn Company Profile
Social Media
CXL Ophthalmics Company Twitter Account
Company News
CXL Ophthalmics News
CXL Ophthalmics on Facebook
CXL Ophthalmics on YouTube

Management Team

Email & Social
Chief Executive Officer
Michael Webb
  Michael Webb LinkedIn Profile  Michael Webb Twitter Account  Michael Webb News  Michael Webb on Facebook
Chief Medical Officer
Michael Belin
  Michael Belin LinkedIn Profile  Michael Belin Twitter Account  Michael Belin News  Michael Belin on Facebook
Chief Operating Officer
Edward Parsons
  Edward Parsons LinkedIn Profile  Edward Parsons Twitter Account  Edward Parsons News  Edward Parsons on Facebook
VP - Bus. Development
Alan Russell
  Alan Russell LinkedIn Profile  Alan Russell Twitter Account  Alan Russell News  Alan Russell on Facebook
VP - R & D
Kevin Daly
  Kevin Daly LinkedIn Profile  Kevin Daly Twitter Account  Kevin Daly News  Kevin Daly on Facebook



Browse more venture capital transactions:

Prev: 9/30/2022: Klaus venture capital transaction
Next: 10/1/2022: Toragen venture capital transaction


Share this article


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary